Zai Lab aims to raise $200M; Kronos Bio to seek ‘strategic’ options

Plus, news about Al­lo­gene, Telix, Cull­gen, Pul­ma­trix, Gilead, In­no­coll, Durect and Sen­sei:

Zai Lab’s $200M of­fer­ing: The Shang­hai-based drug­mak­er is

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Medicare drug price negotiations

The list is mostly unsurprising but contains fewer cancer drugs than most industry experts had predicted. Credit: MargJohnsonVA via Shutterstock. The Biden Administration has released

Read More »